Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis

Assiut University

Status: Unknown

Conditions: ChAdOx1 nCoV-19 Vaccine

Treatments: Other: ChAdOx1 nCoV-19 vaccine

Study type: Observational

Funder types: Other

Identifiers

NCT05060861

Assiut19

Details and patient eligibility

About

Since the beginning of COVID-19 pandemic, a safe and effective vaccine against infection and development of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed control of the wide spread of COVID-19 and reduce death rates throughout the world. Many clinical trials investigated the immunogenicity of different proposed vaccine including the first distributed vaccine; the ChAdOx1 nCoV-19 vaccine and there is a need to analyze the results of published clinical trials.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participant who received 2 doses of ChAdOx1 nCoV-19 vaccine

Exclusion criteria

• non vaccinated person